Stereoselective Passage of Mefloquine Through the Blood‐Brain Barrier in the Rat

The pharmacokinetics of the enantiomers of mefloquine were studied in the rat after administration of a racemic mixture and of the separate enantiomers (+)‐mefloquine and (–)‐mefloquine.

[1]  G. Koren,et al.  Stereoselective pharmacokinetics of mefloquine in healthy Caucasians after multiple doses. , 1994, Journal of pharmaceutical sciences.

[2]  J. Le bras,et al.  In vitro activity of the enantiomers of mefloquine, halofantrine and enpiroline against Plasmodium falciparum. , 1992, British journal of clinical pharmacology.

[3]  P. Moron,et al.  Acute depressive symptoms after mefloquine treatment. , 1992, The American journal of psychiatry.

[4]  M. Trautmann,et al.  Neuropsychiatric side effects after the use of mefloquine. , 1991, The American journal of tropical medicine and hygiene.

[5]  L. Kerr,et al.  Neuropsychiatric side effects of mefloquine. , 1990, The New England journal of medicine.

[6]  A. Björkman.  ACUTE PSYCHOSIS FOLLOWING MEFLOQUINE PROPHYLAXIS , 1989, The Lancet.

[7]  K. Akahane,et al.  Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites , 1989, Antimicrobial Agents and Chemotherapy.

[8]  F. Jamali,et al.  Enantioselective aspects of drug action and disposition: therapeutic pitfalls. , 1989, Journal of pharmaceutical sciences.

[9]  R. Ligthelm,et al.  ACUTE PSYCHOSIS AFTER MEFLOQUINE , 1989, The Lancet.

[10]  J. Vienne,et al.  Mefloquine and an acute brain syndrome. , 1989, Annals of internal medicine.

[11]  V. Kyle,et al.  PROSTAGLANDIN E1 AND PERIPHERAL VASCULAR DISEASE , 1983, The Lancet.

[12]  K. Pettigrew,et al.  Drug entry into the brain , 1979, Brain Research.

[13]  N. Molek,et al.  The absorption, distribution, and excretion in mice of the antimalarial mefloquine, erythro-2,8-bis(trifluoromethyl)-alpha-(2-piperidyl)-4-quinolinemethanol hydrochloride. , 1978, Drug metabolism and disposition: the biological fate of chemicals.

[14]  H. Keen,et al.  ORAL HYPOGLYCÆMICS IN DIABETES MELLITUS , 1975, The Lancet.

[15]  F. Carroll,et al.  OPTICAL ISOMERS OF ARYL‐2‐PIPERIDYLMETHANOL ANTIMALARIAL AGENTS, PREPARATION, OPTICAL PURITY, AND ABSOLUTE STEREOCHEMISTRY , 1974 .

[16]  F. Carroll,et al.  Optical isomers of aryl-2-piperidylmethanol antimalarial agents. Preparation, optical purity, and absolute stereochemistry. , 1974, Journal of medicinal chemistry.

[17]  L. Iversen,et al.  REGIONAL STUDIES OF CATECHOLAMINES IN THE RAT BRAIN‐I , 1966, Journal of neurochemistry.

[18]  L. Iversen,et al.  Regional studies of catecholamines in the rat brain. 3. Subcellullar distribution of endogenous and exogenous catecholamines in various brain regions. , 1966, Biochemical pharmacology.

[19]  N. Greig.  Drug Entry Into the Brain and Its Pharmacologic Manipulation , 1992 .

[20]  Donald W. Miller,et al.  Brain uptake of drugs : the influence of chemical and biological factors , 1992 .

[21]  J. Le bras,et al.  Absence of antimalarial activity or interaction with mefloquine enantiomers in vitro of the main human metabolite of mefloquine. , 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[22]  Y. Osada,et al.  Structure-Epileptogenicity Relationship ofQuinolones withSpecial Reference toTheir Interaction with-y-Aminobutyric AcidReceptor Sites , 1989 .